Life Sciences Part 1 “Keeping the lights on – how do you raise money from UK and international investors to sustain your next phase of growth?”
The COVID pandemic has galvanised interest in the life sciences sector among investors. The UK Bioindustry Association (BIA) recently published a report on UK biotech financing for 2021, which shows that a record £4.5bn was invested into UK life sciences companies in 2021.
During this session our Life Sciences team of experts will cover the funding journey:
• Private equity capital v debt-based private capital
• Tips for acquiring private capital
• Monetising your intellectual property
• Preparing for funding
Date: Friday 4th March 2022
Claus Andersen – Funding/Investment Partner, Corporate – Freeths
Iona Silverman – Intellectual Property Partner – Freeths
Peter Jennings – Partner, Corporate Finance – Healthcare & Thames Valley – Grant Thornton
Jesper Ronald Petersen – Investor
Colin Aaronson – Director, Corporate Finance – Healthcare – Grant Thornton
Vadim Alexandre – Head of Healthcare – SP Angel Corporate Finance
David Hignell – SP Angel Corporate Finance
Tim Davies – Regional Head, UK Primary Markets – The London Stock Exchange Plc
‘Doing the right thing’ is at the heart of Freeths. Find out more about our excellent client service and the strong set of values that guide the way we work.
Talk to us
Freeths are a leading national law firm with 13 offices across the UK. If you have a query about our services or just want to find out more, why not give us a call?
Contact: 03301 001 014